Stifel Financial Corp Anixa Biosciences Inc Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.86 - $5.0 $77,200 - $100,000	20,000 Added 66.67%	50,000 $215,000
Q4 2022 Feb 13, 2023	BUY	$3.78 - $5.81 $113,400 - $174,300	30,000 New	30,000 $127,000
Q3 2021 Nov 15, 2021	SELL	$3.57 - $5.6 $71,400 - $112,000	-20,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.27 - $7.14 $65,400 - $142,800	20,000 New	20,000 $94,000

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $76M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.